Lorlatinib: An additional option for ALK-positive non-small cell lung cancer?

Alice Mogenet, Pascale Tomasini, Laurent Greillier, Fabrice Barlesi

Résultats de recherche: Contribution à un journal › !!Comment/debate

4 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	S383-S386
journal	Translational Lung Cancer Research
Volume	8
Les DOIs	https://doi.org/10.21037/tlcr.2019.05.10
état	Publié - 1 déc. 2019
Modification externe	Oui

Accès au document

@article{cc86b07c792d458f81387fc7345ad1e3,

title = "Lorlatinib: An additional option for ALK-positive non-small cell lung cancer?",

author = "Alice Mogenet and Pascale Tomasini and Laurent Greillier and Fabrice Barlesi",

year = "2019",

month = dec,

day = "1",

doi = "10.21037/tlcr.2019.05.10",

language = "English",

volume = "8",

pages = "S383--S386",

journal = "Translational Lung Cancer Research",

issn = "2218-6751",

}

TY - JOUR

T1 - Lorlatinib

T2 - An additional option for ALK-positive non-small cell lung cancer?

AU - Mogenet, Alice

AU - Tomasini, Pascale

AU - Greillier, Laurent

AU - Barlesi, Fabrice

PY - 2019/12/1

Y1 - 2019/12/1

UR - http://www.scopus.com/inward/record.url?scp=85083094982&partnerID=8YFLogxK

U2 - 10.21037/tlcr.2019.05.10

DO - 10.21037/tlcr.2019.05.10

M3 - Comment/debate

AN - SCOPUS:85083094982

SN - 2218-6751

VL - 8

SP - S383-S386

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

ER -